W
William Y. Chey
Researcher at University of Rochester
Publications - 177
Citations - 10319
William Y. Chey is an academic researcher from University of Rochester. The author has contributed to research in topics: Secretin & Gastrointestinal hormone. The author has an hindex of 43, co-authored 177 publications receiving 9931 citations. Previous affiliations of William Y. Chey include New England Baptist Hospital & University of Texas System.
Papers
More filters
Journal ArticleDOI
Infliximab Maintenance Therapy for Fistulizing Crohn's Disease
Bruce E. Sands,Frank H. Anderson,Charles N. Bernstein,William Y. Chey,Brian G. Feagan,Richard N. Fedorak,Michael A. Kamm,Joshua R. Korzenik,Bret A. Lashner,Jane E. Onken,Daniel Rachmilewitz,Paul Rutgeerts,Gary Wild,Douglas C. Wolf,Paul Marsters,Suzanne Travers,Marion Blank,Sander J. H. van Deventer +17 more
TL;DR: Patients with fistulizing Crohn's disease who have a response to induction therapy with inflIXimab have an increased likelihood of a sustained response over a 54-week period if infliximab treatment is continued every 8 weeks.
Journal ArticleDOI
Practice guidelines in acute pancreatitis.
Peter A. Banks,Martin L. Freeman,Ronnie Fass,Darren Baroni,Ece Mutlu,David E. Bernstein,Henry P. Parkman,Adil E. Bharucha,Charlene M. Prather,William R. Brugge,Daniel S. Pratt,Lin Chang,Albert Roach,William Y. Chey,Richard E. Sampliner,Matthew E. Cohen,Subbaramiah Sridhar,John T. Cunningham,Nimish Vakil,Steven A. Edmundowicz,Miguel A. Valdovinos,John M. Inadomi,Benjamin C.Y. Wong,Timothy R. Koch,Alvin M. Zfass +24 more
TL;DR: These guidelines are developed under the auspices of the American College of Gastroenterology and its practice parameters committee and may be updated with pertinent scientific developments at a later time.
Journal ArticleDOI
ACG practice guidelines: esophageal reflux testing
Ikuo Hirano,Joel E. Richter,Ronnie Fass,Darren Baroni,David E. Bernstein,Adil E. Bharucha,William R. Brugge,Lin Chang,William Y. Chey,Matthew E. Cohen,John T. Cunningham,Steven A. Edmundowicz,John M. Inadomi,Timothy R. Koch,Ece Mutlu,Henry P. Parkman,Charlene M. Prather,Daniel S. Pratt,Albert Roach,Richard E. Sampliner,Subbaramiah Sridhar,Nimish Vakil,Miguel A. Valdovinos,Benjamin C.Y. Wong,Alvin M. Zfass +24 more
TL;DR: Guidelines for esophageal reflux testing are developed under the auspices of the American College of Gastroenterology and its Practice Parameters Committee and approved by the Board of Trustees.
Journal ArticleDOI
A randomized controlled clinical trial of the serotonin type 3 receptor antagonist alosetron in women with diarrhea-predominant irritable bowel syndrome.
Michael Camilleri,William Y. Chey,Emeran A. Mayer,AR Northcutt,AT Heath,George E. Dukes,David McSorley,Allen M. Mangel +7 more
TL;DR: Alosetron hydrochloride, 1 mg twice daily for 12 weeks, is effective in relieving pain and some bowel-related symptoms in diarrhea-predominant female patients with IBS.
Journal ArticleDOI
Electrogastrographic study of patients with unexplained nausea, bloating, and vomiting.
TL;DR: In a group of patients with unexplained nausea, epigastric bloating, and vomiting, abnormal antral myoelectric activities were found by a peroral electrode, in contrast to a regular pacesetter potential in control subjects.